UMIN ID: C000000134
Registered date:12/09/2005
Phase II study of topotecan and cisplatin for elderly small-cell lung cancer
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Elderly small-cell lung cancer |
| Date of first enrollment | 2004/12/01 |
| Target sample size | 55 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Combination chemotherapy of topotecan and cisplatin |
Outcome(s)
| Primary Outcome | Response rate |
|---|---|
| Secondary Outcome | Adverse events, overall survival, 1-year survival rate |
Key inclusion & exclusion criteria
| Age minimum | 76years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Active concomitant malignancy Active interstitial pneumonia Massive effusions Unstable angina, recent myocardial infarction Uncontrolled diabetes Symptomatic brain metastasis Severe active infection Other severe complications Inappropriate condition for this study judged by physicians. |
Related Information
| Primary Sponsor | Okayama Lung Cancer Study Group |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | none |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Nagio Takigawa |
| Address | 2-5-1 Shikata-cho, Okayama 700-8558 Japan |
| Telephone | 086-235-7227 |
| ntakigaw@md.okayama-u.ac.jp | |
| Affiliation | Okayama Lung Cancer Study Group Coordinating Office Okayama University Hospital, Respiratory Medicine |
| scientific contact | |
| Name | Mitsune Tanimoto |
| Address | 2-5-1 Shikata-cho, Okayama 700-8558 Japan |
| Telephone | 086-235-7227 |
| Affiliation | Okayama University Hospital Hematology, Oncology, Respiratory Medicine |